Given the wide use of a choline-deficient, high-fat diet (CD-HFD) to induce a mouse model of NASH, we further examined whether CD-HFD alters the choline levels and serum marker levels in Gde5+/− and WT mice. This evidence concerns the gene GPCPD1 and metabolic dysfunction-associated steatohepatitis.